Finding the Way – Strategies to Make Cell Therapies Successful in Solid Tumors

Adoptive cellular therapy (ACT) has revolutionized the fight against hematological malignancies and holds significant clinical promise against solid tumors. Novel technologies using different immune cells are being investigated, and the list of targets has increased exponentially in the past few years. Despite advances in the field, targeting solid tumors remain challenging due to several factors.

In this research briefing, we discuss the various aspects of ACT in solid tumors with an emphasis on the strategies employed to overcome these challenges.

Download your copy of the research briefing and request a meeting with the FutureBridge Oncology Team.